Omeros Retires Another $14.5M in Convertible Notes, Bringing Total Buyback to $30.5M
OMER has more than doubled off its 52-week low of $3.34.
Summary
By retiring another $14.5 million of its 2029 convertible notes, Omeros further reduces potential dilution and highlights its financial strength after returning to profitability.
Key Events · Financing and Capital Events · OMER
-
Note Repurchase Completed
A total of $14.5 million principal amount of 9.50% Convertible Senior Notes due 2029 was repurchased for $29.0 million, a sum that includes accrued interest and obligations.
-
Total Debt Reduction
When combined with prior repurchases, the company has now retired $30.5 million of the notes, leaving $40.3 million outstanding.
-
Dilution Risk Mitigated
Retiring convertible notes reduces potential future share dilution, a clear positive for existing shareholders.
-
Follows Prior Buyback Programs
This repurchase is part of a series of note buybacks announced in June and July 2026, reflecting a strategy to clean up the balance sheet.
Analysis · OMER · Life Sciences
The company completed a repurchase of $14.5 million in convertible notes for $29 million, pushing total retired debt to $30.5 million. This move curtails future dilution risk from the 2029 notes and underscores management's confidence in cash generation following the YARTEMLEA launch. With $40.3 million in notes still outstanding, the remaining overhang appears manageable.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OMER was trading at $9.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $697M. The 52-week trading range was $3.34 to $17.65. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.